Cargando…

Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy

OBJECTIVE: To inform impending postcolposcopy guidelines, this analysis examined the subsequent risk of CIN 3+ among women with a grade lower than CIN 2 (< CIN 2) colposcopy results, taking into account the referring results that brought them to colposcopy and cotest results postcolposcopy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demarco, Maria, Cheung, Li C., Kinney, Walter K., Wentzensen, Nicolas, Lorey, Thomas S., Fetterman, Barbara, Poitras, Nancy E., Befano, Brian, Castle, Philip E., Schiffman, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Original Research Articles: Cervix and HPV
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895141/ https://www.ncbi.nlm.nih.gov/pubmed/29570564 http://dx.doi.org/10.1097/LGT.0000000000000382

Ejemplares similares

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance
por: Clarke, Megan A., et al.
Publicado: (2020)

Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador
por: Cremer, Miriam, et al.
Publicado: (2017)

Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador
por: Cremer, Miriam L., et al.
Publicado: (2016)

Digital Colposcopy With Dynamic Spectral Imaging for Detection of Cervical Intraepithelial Neoplasia 2+ in Low-Grade Referrals: The IMPROVE-COLPO Study
por: Cholkeri-Singh, Aarathi, et al.
Publicado: (2018)

Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
por: Beylerian, Emily N., et al.
Publicado: (2018)

Outcomes of Conservative Management of High Grade Squamous Intraepithelial Lesions in Young Women
por: Lee, Marette H., et al.
Publicado: (2018)

Importance of Colposcopy Impression in the Early Diagnosis of Posthysterectomy Vaginal Cancer
por: Cong, Qing, et al.
Publicado: (2019)

Impact of Age at Conization on Obstetrical Outcome: A Case-Control Study
por: Chevreau, Julien, et al.
Publicado: (2017)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
por: Eun, Byung-Wook, et al.
Publicado: (2023)

Social and psychological impact of HPV testing in cervical screening: a qualitative study
por: McCaffery, K, et al.
Publicado: (2006)

Multiple infections containing the top five prevalent HPV genotypes and their impact on cervical lesions in Changzhou, China
por: Gong, Ping, et al.
Publicado: (2023)

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Egemen, Didem, et al.
Publicado: (2020)

AN UPWARD TREND IN DNA P16INK4A METHYLATION PATTERN AND HIGH RISK HPV INFECTION ACCORDING TO THE SEVERITY OF THE CERVICAL LESION
por: Carestiato, Fernanda Nahoum, et al.
Publicado: (2013)

An investigation on cervical cancer and human papillomavirus vaccine knowledge, and analysis of influencing factors for choosing domestic or imported 2vHPV vaccine among females in Shenzhen, China
por: Chen, Linxiang, et al.
Publicado: (2023)

Evaluation of a Cervicography-Based Program to Ensure Quality of Visual Inspection of the Cervix in HIV-Infected Women in Johannesburg, South Africa
por: Firnhaber, Cynthia, et al.
Publicado: (2015)

A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines
por: Demarco, Maria, et al.
Publicado: (2020)

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2023)

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
por: Demarco, Maria, et al.
Publicado: (2020)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
por: Wentzensen, Nicolas, et al.
Publicado: (2019)

Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration
por: Miller, Meagan E., et al.
Publicado: (2023)

Engaging health plans to prioritize HPV vaccination and initiate at age 9
por: Foley, Shaylen, et al.
Publicado: (2023)

Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10
por: Kahn, Benjamin Z., et al.
Publicado: (2023)

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US
por: Saxena, Kunal, et al.
Publicado: (2023)

Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review
por: Khan, Amal, et al.
Publicado: (2023)

Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series
por: Kajtezovic, Sidika, et al.
Publicado: (2023)

Parents’ willingness to vaccinate their daughters with human papillomavirus vaccine and associated factors in Debretabor town, Northwest Ethiopia: A community-based cross-sectional study
por: Aragaw, Getie Mihret, et al.
Publicado: (2023)

The association of initiating HPV vaccination at ages 9–10 years and up-to-date status among adolescents ages 13–17 years, 2016-2020
por: Minihan, Adair K., et al.
Publicado: (2023)

Implementing interventions to start HPV vaccination at age 9: Using the evidence we have
por: Brandt, Heather M., et al.
Publicado: (2023)

Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
por: O’Leary, Sonja C., et al.
Publicado: (2023)

HPV vaccine recommendations by age: A survey of providers in federally qualified health centers
por: Lake, Paige, et al.
Publicado: (2023)

Epidemiology of human papillomavirus on condyloma acuminatum in Shandong Province，China
por: Yuan, Haowen, et al.
Publicado: (2023)

Feminized vaccine? Parents’ attitudes toward HPV vaccination of adolescents in Poland: A representative study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
por: Achdiat, Pati Aji, et al.
Publicado: (2023)

Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs
por: Alsanafi, Mariam, et al.
Publicado: (2023)

Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: Success stories from two private pediatric clinics
por: Zorn, Sherri, et al.
Publicado: (2023)

HPV vaccine knowledge, attitudes, and practices among New York State medical providers, dentists, and pharmacists
por: Fernandes, Annlynn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j7155bsvbep1a04k2l7ua5a9mb